Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and …
Over the last 12 months, insiders at Select Medical Holdings Corporation have bought $0 and sold $9.37M worth of Select Medical Holdings Corporation stock.
On average, over the past 5 years, insiders at Select Medical Holdings Corporation have bought $0 and sold $24.96M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,566 shares for transaction amount of $293,066 was made by ORTENZIO ROCCO A (Vice Chairman and Co‑Founder) on 2019‑03‑18.
2024-04-08 | Sale | EXECUTIVE CHAIRMAN | 50,000 0.0392% | $29.90 | $1.5M | +14.04% | ||
2024-03-08 | Sale | EXECUTIVE CHAIRMAN | 50,000 0.039% | $28.30 | $1.42M | +19.22% | ||
2024-02-08 | Sale | EXECUTIVE CHAIRMAN | 50,000 0.0381% | $26.00 | $1.3M | +27.50% | ||
2024-01-08 | Sale | EXECUTIVE CHAIRMAN | 100,000 0.0775% | $26.63 | $2.66M | +23.08% | ||
2023-12-14 | Sale | EXECUTIVE CHAIRMAN | 100,000 0.0782% | $25.00 | $2.5M | +30.83% | ||
2023-09-08 | Sale | EXECUTIVE CHAIRMAN | 50,000 0.0393% | $26.82 | $1.34M | +0.97% | ||
2023-08-08 | Sale | EXECUTIVE CHAIRMAN | 50,000 0.0392% | $29.52 | $1.48M | -8.33% | ||
2023-07-10 | Sale | EXECUTIVE CHAIRMAN | 50,000 0.0408% | $30.36 | $1.52M | -10.29% | ||
2023-06-29 | Sale | EXECUTIVE CHAIRMAN | 100,000 0.0812% | $32.00 | $3.2M | -14.95% | ||
2023-06-21 | Sale | EXECUTIVE CHAIRMAN | 33,967 0.0274% | $30.00 | $1.02M | -9.54% | ||
2023-06-08 | Sale | EXECUTIVE CHAIRMAN | 50,000 0.0405% | $28.63 | $1.43M | -5.06% | ||
2023-05-08 | Sale | EXECUTIVE CHAIRMAN | 166,033 0.1355% | $29.76 | $4.94M | -7.81% | ||
2023-05-08 | Sale | VICE PRESIDENT, COMPLIANCE | 10,044 0.0081% | $29.45 | $295,796 | -7.81% | ||
2023-02-27 | Sale | PRESIDENT AND CEO | 139,550 0.1142% | $27.30 | $3.81M | -1.24% | ||
2021-08-09 | Sale | President and CEO | 139,550 0.1077% | $36.14 | $5.04M | -25.04% | ||
2021-08-09 | Sale | director | 10,000 0.0077% | $36.23 | $362,300 | -25.04% | ||
2021-08-02 | Sale | Executive Vice President | 57,597 0.0443% | $39.54 | $2.28M | -31.44% | ||
2021-06-16 | Sale | Executive Vice President | 100,000 0.0769% | $42.61 | $4.26M | -31.23% | ||
2021-06-15 | Sale | director | 10,000 0.0076% | $42.38 | $423,800 | -31.43% | ||
2021-05-28 | Sale | Executive Vice President | 50,000 0.0383% | $40.07 | $2M | -24.09% |
NORTH TIDE CAPITAL, LLC | 10 percent owner | 13000000 10.0412% | $39.54 | 1 | 5 | +2.98% |
ORTENZIO ROCCO A | Vice Chairman and Co-Founder | 5318374 4.1079% | $39.54 | 4 | 8 | +8.03% |
CROSS DAVID W | Executive Vice President | 284028 0.2194% | $39.54 | 1 | 0 | <0.0001% |
Frist William H. | director | 164334 0.1269% | $39.54 | 1 | 0 | <0.0001% |
T. Rowe Price | $518.65M | 13.23 | 17.2M | +0.53% | +$2.73M | 0.06 | |
BlackRock | $497.08M | 12.68 | 16.49M | -2.12% | -$10.76M | 0.01 | |
The Vanguard Group | $391.89M | 10 | 13M | +5.26% | +$19.6M | 0.01 | |
T Rowe Price Investment Management Inc | $170.75M | 4.36 | 5.66M | -5.05% | -$9.09M | 0.1 | |
Dimensional Fund Advisors | $132.76M | 3.39 | 4.4M | -0.64% | -$858,883.05 | 0.03 |